These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23891730)

  • 1. Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease.
    Santos RR; Torres KC; Lima GS; Fiamoncini CM; Mapa FC; Pereira PA; Rezende VB; Martins LC; Bicalho MA; Moraes EN; Reis HJ; Teixeira AL; Romano-Silva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():1-5. PubMed ID: 23891730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
    Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of costimulatory molecules in dementias.
    Busse S; von Hoff F; Michler E; Hartig R; Bogerts B; Busse M
    Eur Arch Psychiatry Clin Neurosci; 2022 Aug; 272(5):807-815. PubMed ID: 34427746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
    Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
    Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease.
    Vandenborre K; Delabie J; Boogaerts MA; De Vos R; Lorré K; De Wolf-Peeters C; Vandenberghe P
    Am J Pathol; 1998 Apr; 152(4):963-73. PubMed ID: 9546357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated T cells can induce high levels of CTLA-4 expression on B cells.
    Kuiper HM; Brouwer M; Linsley PS; van Lier RA
    J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7.
    Nestle FO; Thompson C; Shimizu Y; Turka LA; Nickoloff BJ
    Cell Immunol; 1994 Jun; 156(1):220-9. PubMed ID: 7515331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential prospective memory profiles in frontotemporal dementia syndromes.
    Kamminga J; O'Callaghan C; Hodges JR; Irish M
    J Alzheimers Dis; 2014; 38(3):669-79. PubMed ID: 24056089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
    Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
    J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.